Prosecution Insights
Last updated: November 12, 2026
Application No. 19/379,637

BROAD-SPECTRUM, MINERAL, PHOTOPROTECTIVE COMPOSITIONS

Final Rejection §103§112
Filed
Nov 04, 2025
Priority
Mar 23, 2018 — continuation of 15/934,312 +1 more
Examiner
LIU, TRACY
Art Unit
1614
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Lcs Advanced Solutions LLC
OA Round
2 (Final)
54%
Grant Probability
Moderate
3-4
OA Rounds
81%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allowance Rate
375 granted / 690 resolved
-5.7% vs TC avg
Strong +26% interview lift
Without
With
+26.3%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
86 currently pending
Career history
795
Total Applications
across all art units

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims included in the prosecution are claims 17-44. Applicants' arguments, filed 08/03/2026, have been fully considered. Rejections and/or objections not reiterated from previous office actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claim 17 is rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. This is a new matter rejection. Claim 17 recites wherein each of the polyglyceryl fatty acid ester compounds of the mixture of polyglyceryl fatty acid ester compounds is present in an amount of 2 wt. to 6 wt. %. The claim fails to comply with the written description requirement since this limitation is not supported in the specification. At best, paragraph [0094] of the specification discloses about 2.25% to about 6% emulsifier. An amount of about 2.25% does not necessarily encompass the entire range of about 2 wt. %. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. 1. Claims 17-43 are rejected under 35 U.S.C. 103 as being unpatentable over Halpern Chirch et al. (US 2018/0263869, Sep. 20, 2018) (hereinafter Halpern Chirch) in view of McCormick et al. (US 2010/0310871, Dec. 9, 2010) (hereinafter McCormick), SaNogueira et al. (US 2003/0059383, Mar. 27, 2003) (hereinafter SaNogueira), Singleton (US 2012/0014882, Jan. 19, 2012), Elementis Specialties (Color Cosmetic Formulary, Apr. 2008), Jones (US 2011/0171148, Jul. 14, 2011), Candau et al. (US 2009/0041691, Feb. 12, 2009) (hereinafter Candau), and Argan. Co (Sun Care, Sep. 14, 2017), as evidenced by Pitarch Lopez et al. (WO 2020/216676 A1, Oct. 29, 2020) (hereinafter Pitarch Lopez) and Parchem (Polyglyceryl-3 Diisostearate, 2026). Halpern Chirch discloses a sunscreen composition comprising photosensitive capsules, wherein the photosensitive capsules comprise one or more UV filters (abstract). 90% or more of the one or more UV filters is released from the photosensitive capsule within about 1 minute after exposure to UV-A light and/or UV-B light (i.e., broad-spectrum) (¶ [0031]). The at least one UV filter may be one or more inorganic UV filter (¶ [0043]). Suitable inorganic UV filters include titanium oxide, zinc oxide, iron oxide, and cerium oxide (¶ [0046]). The one or more UV filter may be in an amount of about 1 to about 90 wt. % based on the total weight of the sunscreen composition (¶ [0120]). The sunscreen composition may be formulated to have an SPF of 5 to 200 (¶ [0120]). The sunscreen composition may be an emulsion and will typically include one or more emulsifiers (¶ [0036]). The emulsifier is generally present in the composition from 0.3% to 30% (¶ [0124]). Film-formers are often incorporated into sunscreen composition to ensure even coverage of the UV filters and can be used to render the composition water resistant (¶ [0164]). The total amount of film-formers present in the composition is typically about 0.1 to about 25 wt. % (¶ [0167]). The composition may comprise other active ingredients (¶ [0033]). The composition may comprise emollients (¶ [0153]). The total amount of oils/emollient is typically about 0.1 to 40 wt. % (¶ [0162]). The sunscreen composition is made by homogenizing and mixing the ingredients (¶ [0180]). The composition may be transparent (¶ [0018]). Halpern Chirch differs from the instant claims insofar as not disclosing wherein the zinc oxide is porous and has an average particle size of greater than 100 nanometers. However, McCormick discloses mesoporous zinc oxide aggregates for use in visibly-transparent compositions that provide broad-spectrum photoprotection (¶ [0002]). The aggregates may have sizes in the range of 0.1 to 100 microns (¶ [0021]). Suitable transparent compositions include sunscreens (¶ [0051]). Generally, it is prima facie obvious to select a known material for incorporation into a composition, based on its recognized suitability for its intended use. See MPEP 2144.07. The composition of Halpern Chirch comprises zinc oxide. Accordingly, it would have been prima facie obvious to one of ordinary skill in the art to have incorporated the mesoporous zinc oxide of McCormick into the composition of Halpern Chirch since the mesoporous zinc oxide is a known and effective type of zinc oxide for sunscreen compositions as taught by McCormick. The combined teachings of Halpern Chirch and McCormick do not teach wherein the composition comprises a mixture of polyglyceryl fatty acid ester compounds wherein each of the polyglyceryl fatty acid ester compounds contains between 3-6 glycerin units. However, SaNogueira discloses a sunscreen composition (abstract). The composition may comprise an emulsifier such as polyglyceryl-3-diisostearate (i.e., has 3 glycerin units) and polyglyceryl-4 oleate (i.e., has 4 glycerin units) (¶ [0024]). The amount of emulsifier is about 0.01 wt. % to about 5 wt. % (¶ [0026]). Halpern Chirch discloses wherein the composition comprises emulsifiers. Accordingly, it would have been prima facie obvious to one of ordinary skill in the art to have incorporated about 0.01 wt. % to about 5 wt. % polyglyceryl-3-diisostearate and polyglyceryl-4 oleate into the composition of Halpern Chirch since these are known emulsifiers for sunscreen compositions as taught by SaNogueira. With regards to incorporating both polyglyceryl-3-diisostearate and polyglyceryl-4 oleate, since SaNogueira discloses the use of various emulsifiers individually, the use of the individual species in combination would have been obvious since it is prima facie obvious to combine two compositions, each of which is taught by SaNogueira to be useful for the same purpose, in order to form a third composition to be used for the very same purpose; the idea for combining them flows logically from their having been individually taught in the prior art. See MPEP 2144.06. The combined teachings of Halpern Chirch, McCormick, and SaNogueira do not teach wherein the composition comprises (I) bis-vinyl dimethicone/dimethicone copolymer and (II) dimethicone and acrylates/dimethicone copolymer. However, Singleton discloses an anhydrous sunscreen composition (abstract). The composition includes a film forming polymer to enhance film formation and provide some water resistance (¶ [0028]). Suitable film-forming polymers include dimethicone/acrylates dimethicone copolymer (¶ [0029]). The amount of film-forming polymer may be from about 0.25% to about 15% (¶ [0030]). The composition may include a dispersed alkyl-modified silicone polymer (¶ [0031]). The dispersed alkyl-modified silicone generally serves to reduce surface tension, improve water exclusion and reduce whitening. An example of a suitable alkyl-modified silicone polymer includes copolymers of cetyl dimethicone and bis-vinyl dimethicone (¶ [0032]). The amount of dispersed alkyl-modified silicone polymer present in the concentrate may be from about 0.1% to about 1% (¶ [0033]). Halpern Chirch discloses wherein the composition comprises film formers. Accordingly, it would have been prima facie obvious to one of ordinary skill in the art to have incorporated dimethicone/acrylates dimethicone copolymer into the composition of Halpern Chirch since it is a known and effective film forming agent as taught by Singleton. Halpern Chirch also discloses wherein the composition should be rendered water resistant. Accordingly, it would have been prima facie obvious to one of ordinary skill in the art to have incorporated a copolymer of cetyl dimethicone and bis-vinyl dimethicone into the composition of Halpern Chirch to improve water exclusion as taught by Singleton. The combined teachings of Halpern Chirch, McCormick, SaNogueira, and Singleton do not teach wherein the composition comprises a mixture of phenyl trimethicone, disteardimonium hectorite, and triethyl citrate. However, Elementis Specialties discloses wherein Bentone Gel PTM V (Phenyl Trimethicone and Disteardimonium hectorite and Triethyl citrate) improves application, enhances feel properties, and stabilizes formulations (page 5). Halpern Chirch discloses wherein the composition comprises active ingredients. Accordingly, it would have been prima facie obvious to one of ordinary skill in the art to have incorporated Bentone Gel PTM V into the composition of Beasley motivated by the desire to improve application and enhance feel properties as taught by Elementis Specialties. The combined teachings of Halpern Chirch, McCormick, SaNogueira, Singleton, and Elementis Specialties do not teach wherein the composition comprises polyhydroxystearic acid. However, Jones discloses a composition containing at least one sunscreen and a protein-PVP copolymer (abstract). The composition is in the form of an emulsion (or dispersion), such as a water-in-oil emulsion (¶ [0013]). By dispersion it is meant a true dispersion, i.e. where the solid particles are stable to aggregation. The particles in the dispersion are relatively uniformly dispersed and resistant to settling out on standing (¶ [0051]). The dispersion may contain a dispersing agent in order to improve the properties thereof. The dispersing agent is suitably present in the range from 1 to 30% by weight based on the total weight of metal oxide (¶ [0055]). Suitable dispersing agents include polyhydroxystearic acid (¶ [0056]). Accordingly, it would have been prima facie obvious to one of ordinary skill in the art to have incorporated 1-30% polyhydroxystearic acid into the composition of Halpern Chirch motivated by the desire to improve dispersibility since it is a desire property in sunscreen compositions as taught by Jones. The combined teachings of Halpern Chirch, McCormick, SaNogueira, Singleton, Elementis Specialties, and Jones do not teach wherein the composition comprises amorphous spherical silica. However, Candau discloses a topically applicable cosmetic/dermatological UV protection composition (abstract). The composition may comprise fillers capable of modifying and hiding wrinkles by virtue of their intrinsic physical properties (¶ [0544]). Suitable fillers include amorphous silica microspheres (¶ [0562]). The concentration of the filler may be from 0.1% to 40% by weight (¶ [0562]). Accordingly, it would have been prima facie obvious to one of ordinary skill in the art to have incorporated 0.1% to 40% amorphous silica microspheres into the composition of Halpern Chirch in order to formulate a composition capable of modifying and hiding wrinkles since amorphous silica microspheres has such property as taught by Candau. The combined teachings of Halpern Chirch, McCormick, SaNogueira, Singleton, Elementis Specialties, Jones, and Candau do not teach wherein the composition comprises a mixture of diatomaceous algae materials. However, Argan.Co. discloses wherein Plankton Glass Flower is a UV-protection product with absorbant, light scattering, mild exfoliant, and UV reflective properties. As evidenced by paragraph [0080] of the instant specification, Plankton Glass Flower is described as algal photonic and porous silica crystals or alternatively, siliceous fragments of freshwater algae species, mainly Fragilaria zeilleri, Gomphomena angustatum, Navicula radiosa, and Cyclotella andancensis. The composition of Halpern Chirch comprises one or more UV filters. Accordingly, it would have been obvious to have incorporated Plankton Glass Flower into the composition of Halpern Chirch since it is a known and effective UV filter with UV reflecting properties as taught by Argan.Co. In regards to instant claim 17 reciting wherein the zinc oxide particles and the titanium dioxide particles are evenly dispersed in the composition, Halpern Chirch teaches wherein the ingredients of the composition are mixed. Therefore, it would have been obvious to one of ordinary skill in the art that capsules containing the zinc oxide particles and the titanium dioxide particles are evenly dispersed in the composition. In regards to instant claim 17 reciting wherein the combination of two polysiloxane polymer compounds is in an amount such that the film-forming component causes the composition to produce a continuous film on skin when applied thereto, as noted in the instant specification in paragraph [0099], film-forming ingredients are chemicals that produce a continuous film on skin. Paragraph [0101] of the instant specification further discloses wherein film-forming polymers include (i) bis vinyl dimethicone/dimethicone copolymer, commercially available in combination with dimethicone or cetyl dimethicone and (ii) dimethicone (and) acrylates/dimethicone copolymer. Therefore, since film-formers produce a continuous film on skin, and dimethicone/acrylates dimethicone copolymer and a copolymer of cetyl dimethicone and bis-vinyl dimethicone are film-forming ingredients, the composition of the prior art comprising these ingredients would necessarily form a continuous film and thus the amount of these ingredients are in amounts that causes a composition to produce a continuous film. In regards to instant claim 17 reciting wherein the polyhydroxystearic acid is an amount that disperses the mineral oxide particles, boosts the SPF of the composition and reduces composition whitening when the composition is applied to the skin, as noted in paragraph [0131] of the instant specification, polyhydroxystearic acid is incorporated into the claimed invention in an amount of 0.25-1.00%. Thus, 0.25-1.00% is an amount that disperses the mineral oxide particles, boosts the SPF of the composition and reduces composition whitening when the composition is applied to the skin. As discussed in the rejection, Jones discloses 1-30% polyhydroxystearic acid by weight based on the total weight of metal oxide and Halpern Chirch discloses wherein the metal oxide (i.e., zinc oxide and titanium oxide) is from about 1 to about 90 wt. As such, one of ordinary skill in the art would have arrived at an amount of polyhydroxystearic acid in the prior art that overlaps with 0.25-1.00%. As such, the prior art teaches an amount of polyhydroxystearic acid that disperses the mineral oxide particles, boosts the SPF of the composition and reduces composition whitening when the composition is applied to the skin. In regards to instant claim 17 reciting wherein the composition does not cause visible whitening on the skin of a person having a Fitzpatrick Skin Type of I-IV, as noted in the instant specification in paragraph [0009], use of zinc oxide, particularly, at high concentrations, is known to leave a white pasty residue on the skin. Paragraph [0131] further discloses wherein the instant invention comprises 5% or 10% zinc oxide. Accordingly, since Halpern Chirch discloses as low as about 1 wt. % zinc oxide, it would have been obvious to one of ordinary skill in the art that the composition of Halpern Chirch does not cause visible whitening on the skin of a person having a Fitzpatrick Skin Type of I-IV. Also, Halpern Chirch discloses wherein the composition may be transparent; therefore, it should not cause visible whitening. In regards to instant claim 17 reciting wherein the composition is free of polyethylene glycol, Halpern Chirch does not disclose wherein the composition is required to comprise polyethylene glycol. Therefore, a composition free of polyethylene glycol would have been obvious. In regards to instant claim 17 reciting wherein the composition is free of any organic sunscreen active ingredients, Halpern Chirch does not disclose wherein the one or more UV filters has to include organic UV filters (see paragraph [0043] of Halpern Chirch). Therefore, a composition free of organic sunscreen active ingredients would have been obvious. In regards to instant claims 18, 19, 27, 28, 37 and 38, Halpern Chirch does not disclose wherein the composition is required to comprise styrene/acrylates copolymer or butyloctyl salicylate or poly(methyl methacrylate). Therefore, a composition free of these components would have been obvious. In regards to instant claims 20, 29 and 39, Halpern Chirch does not disclose wherein the composition is required to comprise a specific emulsifier or film former, therefore, a composition comprising the claimed emulsifier as the only emulsifier and the claimed film-forming component as the only film-forming component would have been obvious. In regards to instant claims 21, 30 and 40, Halpern Chirch discloses in paragraph [0031] wherein the capsules release their content upon exposure to visible light, i.e., light having a wavelength of about 380 nm to about 750 nm), thus the composition of Halpern Chirch has a critical wavelength of at least 370 nm. Additionally, as noted in paragraph [0015] of the instant specification, the claimed composition achieved a stable emulsion (i.e., one that does not separate into oil and water phases after storage for one month) with a single emulsifier. Therefore, since the composition of the prior art comprises substantially the same emulsifier as claimed, the composition of the prior art necessarily does not separate into oil and water phases after storage for one month like the claimed composition. In regards to instant claims 23, 32, and 43, as noted in the instant specification in paragraph [0100], the composition has a water resistance of 80 minutes from film-forming polysiloxane polymers. Accordingly, since the composition of the prior art comprises substantially the same film-forming polymer as the claimed invention, the composition of the prior art is water resistant for at least 80 minutes. In regards to instant claims 24, 33 and 42, Halpern Chirch does not disclose wherein the composition comprises a dispersant. Therefore, it would have been obvious when incorporating polyhydroxystearic acid into the composition of Halpern Chirch that it is the only polymeric dispersant. In regards to instant claim 25 reciting wherein the ratio of the amorphous spherical silica to the mixture of materials of from different diatomaceous algae species is between about 1:4 to about 50.1, as discussed above, the amount of amorphous silica microspheres is 0.1% to 40% as taught by Candau. Argan. Co. disclose wherein Plankton Glass Flower (i.e., claimed mixture of diatomaceous algae) is a sun-care active and Halpern Chirch discloses wherein one or more UV filters are present in the range of about 1 wt.% to about 90 wt. %. Therefore, claimed ratio would have been obvious from these ranges. In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art”, a prima facie case of obviousness exists. MPEP 2144.05 A. In regards to instant claim 26 reciting wherein the iron oxide particles are in an amount sufficient to impart a tint to the composition, as noted in the instant specification in paragraph [0071], iron oxide may be present from about 1.0 to 7.0%. Halpern Chirch discloses wherein one or more UV filters are present in the range of about 1 wt.% to about 90 wt. %. Therefore, it would have been obvious to one of ordinary skill in the art that Halpern Chirch discloses an amount of iron oxide particles that would impart a tint to the composition. In regards to instant claim 36, as evidenced by Pitarch Lopez, polyglyceryl-4-oleate has an HLB of 4-6 (page 6, line 26). As evidenced by Parchem, polyglyceryl-3-diisostearate has an HLB of 7.5. 2. Claim 44 is rejected under 35 U.S.C. 103 as being unpatentable over Halpern Chirch et al. (US 2018/0263869, Sep. 20, 2018) (hereinafter Halpern Chirch) in view of McCormick et al. (US 2010/0310871, Dec. 9, 2010) (hereinafter McCormick), SaNogueira et al. (US 2003/0059383, Mar. 27, 2003) (hereinafter SaNogueira), Singleton (US 2012/0014882, Jan. 19, 2012), Elementis Specialties (Color Cosmetic Formulary, Apr. 2008), Jones (US 2011/0171148, Jul. 14, 2011), Candau et al. (US 2009/0041691, Feb. 12, 2009) (hereinafter Candau), Argan. Co (Sun Care, Sep. 14, 2017), and further in view of Meyer et al. (US 2003/0044364, Mar. 6, 2003) (hereinafter Meyer). The teachings of Halpern Chirch, McCormick, SaNogueira, Singleton, Elementis Specialties, Jones, Candau, and Argan. Co are discussed above. Halpern Chirch, McCormick, SaNogueira, Singleton, Elementis Specialties, Jones, Candau, and Argan. Co do not teach wherein the composition comprises about 0.5 wt. % to about 2 wt. %. However, Meyer discloses a formulation for topical application comprising at least one sunscreen active agent (abstract). The composition may comprise an emollient such as squalane (¶ [0029]). Halpern Chirch discloses wherein the composition comprises about 0.1 to about 40 wt. % emollients. Accordingly, it would have been prima facie obvious to one of ordinary skill in the art to have incorporated squalane into the composition of Halpern Chirch since it is a known and effective emollient as taught by Meyer. Response to Arguments Applicant argues that SaNogueira teaches away from any composition that does not include the presence of a glucoside emulsifier. The Examiner does not find Applicant’s argument to be persuasive. SaNogueira is not the composition being modified in the rejection. SaNogueira requiring a glucoside emulsifier does not mean that another sunscreen composition needs a glucoside emulsifier. As such, Applicant’s argument is unpersuasive. Applicant argues that the mere ability to use Bentone Gel provides absolutely no teaching, suggestion, or other motivation for a skilled artisan to select Bentone Gel, and more specifically, to select Bentone Gel to the exclusion of any other potential choices as the sole agent used as a suspending dispersant in the composition at issue. The Examiner does not find Applicant’s argument to be persuasive. As discussed in the rejection, Bentone Gel improves application and enhances feel properties. Therefore, there is motivation for one of ordinary skill in the art to select Bentone Gel. Since the primary reference does not require a dispersing agent, incorporating Bentone Gel into the primary reference composition will result in a composition comprising Bentone Gel as the sole suspending dispersing component. Although the prior art does not suggest using Bentone Gel as a suspending dispersing component, rationale different from Applicant’s is permissible. The reason or motivation to modify the reference may often suggest what the inventor has done, but for a different purpose or to solve a different problem. It is not necessary that the prior art suggest the combination to achieve the same advantage or result discovered by applicant. See MPEP 2144(IV). As such, Applicant’s argument is unpersuasive. Conclusion Claims 17-44 are rejected. No claims are allowed. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to TRACY LIU whose telephone number is (571)270-5115. The examiner can normally be reached Mon-Fri 9 am - 5 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ali Soroush can be reached at 571-272-9925. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /TRACY LIU/Primary Examiner, Art Unit 1614
Read full office action

Prosecution Timeline

Nov 04, 2025
Application Filed
Apr 02, 2026
Non-Final Rejection mailed — §103, §112
Aug 03, 2026
Response Filed
Aug 13, 2026
Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778871
COSMETIC COMPOSITION COMPRISING A COMBINATION OF TWO PARTICULAR COUPLERS AND N,N-DICARBOXYMETHYLGLUTAMIC ACID AND/OR ITS SALTS
3y 4m to grant Granted Nov 03, 2026
Patent 12767888
PREPARATION METHOD FOR DEGRADABLE LIQUID-STATE MULCHING FILM BY USING LIVESTOCK MANURE AS RAW MATERIAL
2y 2m to grant Granted Oct 20, 2026
Patent 12714656
AQUEOUS ORAL CARE IODIDE-CONTAINING COMPOSITIONS, METHODS, AND KITS
2y 11m to grant Granted Aug 25, 2026
Patent 12636246
PROCESS FOR COLOURING HAIR KERATIN FIBERS, COMPRISING THE APPLICATION OF A COMPOSITION COMPRISING AT LEAST ONE (POLY)CARBODIIMIDE COMPOUND AND A COMPOSITION COMPRISING AT LEAST ONE ASSOCIATIVE POLYMER AND A PARTICULAR COMPOUND
2y 8m to grant Granted May 26, 2026
Patent 12605314
BROAD-SPECTRUM, MINERAL, PHOTOPROTECTIVE COMPOSITIONS
2y 9m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
54%
Grant Probability
81%
With Interview (+26.3%)
Moderate
PTA Risk
Based on 690 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month